4.4 Review

Recent Advances in 3D Bioprinted Tumor Microenvironment

Journal

BIOCHIP JOURNAL
Volume 14, Issue 2, Pages 137-147

Publisher

KOREAN BIOCHIP SOCIETY-KBCS
DOI: 10.1007/s13206-020-4201-8

Keywords

Tumors; 3D Bioprinting; Microenvironment; Metastasis; Method

Funding

  1. National Research Foundation (NRF) of Korea [2018R1A2B2002066, 2016M3A9B 4917320]
  2. Institute of Information & Communications Technology Planning & Evaluation (IITP) [2019-0-00047]
  3. Ministry of Science and ICT (MSIT) in Korea
  4. National Research Foundation of Korea [2018R1A2B2002066] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Tumors in vivo exist in a microenvironment, so-called tumor microenvironment (TME), which includes peripheral blood vessels, immune cells, fibroblasts, signalling molecules and extracellular matrix. In recent years, considerable efforts have been focused on developing bioprinting methods because 3D bioprinting can better recapitulate TMEs by accurately printing different types of TME cells in spatially localised regions. In this review, we first introduce TME and 3D bioprinting methods and later discuss bioprinted TMEs as tumor equivalents for understanding tumor biology as well as testing drug efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available